glp 1 neuroprotection GLP-1 mimetics and cognition Incretin and insulin signaling as

Exposures New users of GLP-1RA were separately compared with new users of dipeptidyl peptidase-4 inhibitors (DPP4i) and sodium-glucose cotransporter 2 inhibitors (SGLT2i), using 1:1 propensity score matching to adjust for differences in patient characteristics

Many people notice a quick drop in pounds during the first few weeks

Discover how quickly GLP-1 medications like semaglutide and liraglutide start working, what to expect in the first few weeks, and the realistic timeline for blood sugar control and weight loss results.

Understanding proper storage and shelf life helps you get the most from your weight loss therapy

What the 2025 Gastroenterology Metaanalysis Found The systematic review and metaanalysis (DOI: 10.1053/j.gastro.2025.06.003) evaluated safety outcomes across randomized trials and realworld studies of GLP1 RAs